   |
|
 |
|
Investments
Enter information to receive updates
Technology & Biotechnology
Not all investees are displayed - click on Disclosure Criteria link for explanation
Click here to read Pinetree's Disclosure Criteria
Since its inception, Pinetree has invested in technology and biotechnology companies. Our successful track record of investing in these areas gave us the financial footing to pursue resource investment opportunities in early 2002. While our current focus is on the resource sector, we continue to hold investments in the technology and biotechnology sectors. We are always looking for new compelling opportunities and occasionally invest in new technology and biotechnology companies which we believe will create a strong return for our shareholders.
Investments as at June 30, 2010.
Antisense Therapeutics Limited (ANP:ASX)
37,500,000 common shares
GeneNews Ltd. (GEN:TSX)
3,181,500 common shares
View22 Technology Inc. (Private)
1,138,000 common shares
$525,000 convertible debenture
150,000 warrants expire Jul 8, 2010
500,000 warrants expire Aug 2, 2010
